Craig Collard's Trading History
| HRTXHeron Therapeutics | Oct 21, 2026 | CEO, Director | Uninformative Buy | 3.76K | $240.14K | |
| OPNTOpiant Pharmaceuticals | Mar 03, 2023 | ― | Uninformative Sell | 1.08M | $0.00 | |
| SRRASierra Oncology | Jul 01, 2022 | ― | Uninformative Sell | 742.50K | $0.00 | |
| ~CRTXCornerstone Therapeutics Inc | Feb 04, 2014 | ― | Uninformative Sell | 427.50K | ― |
You May Also Like
Craig Collard insider profile FAQ
What is the percentage of profitable transactions made by Craig Collard?
The percentage of profitable transactions made by Craig Collard is 33%.
What is the average return per transaction made by Craig Collard?
The average return per transaction made by Craig Collard is -26.10%.
What stocks does Craig Collard hold?
Craig Collard holds: HRTX, ~CRTX, SRRA, OPNT stocks.
What was Craig Collard’s latest transaction?
Craig Collard’s latest transaction was an Uninformative Buy of $3.76K.
What was Craig Collard's most profitable transaction?
Craig Collard’s most profitable transaction was an Informative Buy of HRTX stock on November 17, 2023. The return on the trade was 9.10%.
What is Craig Collard's role in Heron Therapeutics?
Craig Collard's role in Heron Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.